Literature DB >> 9058310

Primary sclerosing cholangitis in Japan--analysis of 192 cases.

H Takikawa1, T Manabe.   

Abstract

Primary sclerosing cholangitis is very rare in Japan. The aim of the present study was to identify the characteristics of such patients in Japan. A questionnaire was sent to the members of the Japanese Society of Gastroenterology and responses for 192 cases were analyzed. There was male predominancy (61%), and two peaks in the age distribution at diagnosis (20-30 years and 50-70 years). Bile duct damage was mainly intra + extrahepatic (69%) versus intrahepatic (17%) or extrahepatic (14%). The incidences of eosinophilia and positivity for anti-nuclear antibody were 27% and 30%, respectively. The incidence of associated inflammatory bowel disease was 21% (38 ulcerative colitis and 2 Crohn's disease). Chronic pancreatitis, gallstones, and biliary cancers occurred in 15%, 12%, and 4%, respectively, of the 192 patients. Patients less than 40 years of age had a higher incidence than the patients 40 years old or more of damage intra + extrahepatic bile ducts (89% vs 56%) and of associated ulcerative colitis (36% vs 9%), whereas the incidence of chronic pancreatitis was lower in patients aged less than 40 years (4%). The characteristics of patients with primary sclerosing cholangitis in Japan differ from those in other countries in regard to age distribution and the incidence of complications, and at least two different groups of patients seem to exist in terms of the degree of bile duct damage and the incidence of complications.

Entities:  

Mesh:

Year:  1997        PMID: 9058310     DOI: 10.1007/bf01213311

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  11 in total

1.  Surgical aspects of sclerosing cholangitis. Results in 178 patients.

Authors:  F M Martin; R L Rossi; F W Nugent; F J Scholz; R L Jenkins; W D Lewis; M Gagner; E Foley; J W Braasch
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

2.  Natural history and prognostic variables in primary sclerosing cholangitis.

Authors:  J M Farrant; K M Hayllar; M L Wilkinson; J Karani; B C Portmann; D Westaby; R Williams
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

3.  Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.

Authors:  A Stiehl; S Walker; L Stiehl; G Rudolph; W J Hofmann; L Theilmann
Journal:  J Hepatol       Date:  1994-01       Impact factor: 25.083

4.  A case of primary sclerosing cholangitis.

Authors:  H Shiraoku; M Hokamura; K Sagara; S Fujiyama
Journal:  Gastroenterol Jpn       Date:  1985-08

5.  Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.

Authors:  M Rabinovitz; J S Gavaler; R R Schade; V J Dindzans; M C Chien; D H Van Thiel
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

6.  Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.

Authors:  C B O'Brien; J R Senior; R Arora-Mirchandani; A K Batta; G Salen
Journal:  Hepatology       Date:  1991-11       Impact factor: 17.425

7.  Risk factors in primary sclerosing cholangitis.

Authors:  E Schrumpf; M Abdelnoor; O Fausa; K Elgjo; E Jenssen; F Kolmannskog
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

8.  Current concepts. Primary sclerosing cholangitis.

Authors:  N F LaRusso; R H Wiesner; J Ludwig; R L MacCarty
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

9.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.

Authors:  H Asakura; M Tsuchiya; S Aiso; M Watanabe; K Kobayashi; T Hibi; K Ando; H Takata; S Sekiguchi
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

View more
  27 in total

Review 1.  Primary sclerosing cholangitis.

Authors:  S A Mitchell; R W Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Primary sclerosing cholangitis associated with lupus nephritis: a rare association.

Authors:  Yoshiko Kadokawa; Katsuhisa Omagari; Isao Matsuo; Yoshiko Otsu; Umpei Yamamoto; Tomoya Nishino; Kazuo Ohba; Masanobu Miyazaki; Takashi Harada; Takashi Taguchi; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

3.  Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.

Authors:  Masanori Koyabu; Kazushige Uchida; Norimasa Fukata; Takeo Kusuda; Tsukasa Ikeura; Yutaku Sakaguchi; Katsunori Yoshida; Masaaki Shimatani; Toshiro Fukui; Mitsunobu Matsushita; Yoshiko Uemura; Masaki Kaibori; Makoto Takaoka; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2009-09-18       Impact factor: 7.527

4.  The 2016 diagnostic criteria for primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Kenji Notohara; Susumu Tazuma; Atsushi Tanaka; Hiroyuki Isayama; Toshio Tsuyuguchi; Toshiyuki Mori; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2016-12-05       Impact factor: 7.527

5.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

Review 6.  Primary sclerosing cholangitis as an intractable disease.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 7.  Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

Authors:  A Boudewijn de Vries; Marcel Janse; Hans Blokzijl; Rinse K Weersma
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

8.  Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma.

Authors:  Kazuto Fukuda; Sachiyo Kogita; Yusuke Tsuchimoto; Yoshiyuki Sawai; Takumi Igura; Hideko Ohama; Yuki Makino; Yasushi Matsumoto; Masanori Nakahara; Shin-Ichirou Zushi; Yasuharu Imai
Journal:  Clin J Gastroenterol       Date:  2012-04-07

9.  Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis.

Authors:  Terumi Kamisawa; Kensuke Takuma; Hajime Anjiki; Naoto Egawa; Masanao Kurata; Goro Honda; Kouji Tsuruta
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

10.  Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case.

Authors:  Takasuke Fukuhara; Akinori Egashira; Masakazu Imamura; Toru Ikegami; Eiji Oki; Yuji Soejima; Noriaki Sadanaga; Akinobu Taketomi; Takashi Yao; Masaru Morita; Yoshihiro Kakeji; Masazumi Tsuneyoshi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.